Floatz logo

METHOTREXATE

Unrecognized Condition: Mature B or T-cell Neoplasm

Grupo Español de Linfomas y Transplante Autólogo de Médula ÓseaSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Unrecognized Condition: Mature B or T-cell Neoplasm cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2CCC
Campath-1H
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2CC

Same molecule, other indications

METHOTREXATE is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →
acute promyelocytic leukemiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →